retatrutide triple agonist gip glp-1 glucagon receptor From Obesity to Metabolic Health: Why Is a Game-Changer Retatrutide, a GIP, GLP-1 and
Description
However, some patients report leg discomfort anecdotally
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
Mounjaro subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes
However, medical outcomes are heavily dependent on how consistently a patient can follow the required administration rules
After that, the dose increases to 0.5 mg weekly
Keep healthy fat intake at 30 to 50 grams per day
Lademann, E
